Focused Ultrasound Modulation of Hepatic Neural Plexus Restores Glucose Homeostasis in Diabetes

Abstract

While peripheral glucose sensors are known to relay signals of substrate availability to integrative nuclei in the brain, the importance of these pathways in maintaining energy homeostasis and their contribution to disease remain unknown. Herein, we demonstrate that selective activation of the hepatoportal neural plexus via transient peripheral focused ultrasound (pFUS) induces glucose homeostasis in models of well-established insulin resistant diabetes. pFUS modulates sensory projections to the hindbrain and alters hypothalamic concentrations of neurotransmitters that regulate metabolism, resulting in potentiation of hypothalamic insulin signaling, leptin-independent inhibition of the orexigenic neuropeptide Y system, and therapeutic alteration in autonomic output to peripheral effector organs. Multiomic profiling confirms pFUS-induced modifications of key metabolic functions in liver, pancreas, muscle, adipose, kidney, and intestines. Activation of the hepatic nutrient sensing pathway not only restores nervous system coordination of peripheral metabolism in three different species but does so across these organ systems; several of which are current targets of antidiabetic drug classes. These results demonstrate the potential of hepatic pFUS as a novel/non-pharmacologic therapeutic modality to restore glucose homeostasis in metabolic diseases, including type II diabetes.

Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes

“…Despite of the aforementioned possible improvements, our framework shows inspiring translational potentials in precision medicine by enriching the limited options of digital models utilizing medical data collected from wearable devices. For example, with a few slight modifications on the ODE model to address the insulin resistance of tissue, we could model and optimize the insulin usage in patients with type 2 diabetes who develop insulin resistance (54). Interestingly, novel wearable devices are being designed to probe insulin and other metabolites that are impossible to quantify with existing techniques (55,56), which will clearly benefit the calibration and the extension of our framework.…”

Decreasing the blood flow of non-compressible intra-abdominal organs with non-invasive transcutaneous electrical stimulation

“…Radiofrequency ablation of hepatic artery innervation [15,16] has been utilised in glucose metabolism modulation and showed evidence for potential future investigations. In addition, a recent focus ultrasound stimulation that targets hepatoportal nerve plexus also demonstrated the alleviation of Diabetes Type-2 [17]. In this context of above-mentioned studies, non-invasive A10Hz blood ow modulation in CHA has the potential to interact with liver-brain glucose neural regulatory axis and this has to be investigated with further studies.…”

High‐Performing and Capacitive‐Matched Triboelectric Implants Driven by Ultrasound

“…Ultrasound is a promising WPT energy source for AIMD, due to its safety verified in various medical fields (sensing, [13] monitoring, [14] therapy, [15] and even acoustic power transfer [16] ) and its high penetration ability, even in metallic materials. [17] Recently, triboelectric nanogenerators (TENGs) based on the coupling effect of contact electrification and electrostatic induction have attracted particular attention as a useful harvesting technology of ultrasound energy.…”